Skip to main content

Pharmala Biotech Holdings Inc.(MDMA-CN)
CSE

Today's Change
Delayed Last Update

Stocks in play: Pharmala Biotech Holdings Inc

Baystreet - Mon Aug 29, 2022

Announces the filing of a key Patent Cooperation Treaty application, containing 6 Novel Chemical Entities. The application claims priority to, and benefit of a United States provisional patent application filed August 20, 2021. This PCT application disclosed novel compositions of MDMA and analogs thereof which may be used to alleviate the known side effects of MDMA while retaining its efficacy. Pharmala Biotech Holdings Inc shares C.MDMA are trading unchanged at $0.05.

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe